Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Director bought 30,000 shares at $4.21 ($126,300)
  2. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.28 ($21,400)
  3. 4 Open-market buy Director bought 19,000 shares at $4.33 ($82,270)
  4. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.94 ($39,400)
  5. 4 Open-market buy Director bought 12,200 shares at an average $3.99 ($48,730)
  6. 4 Open-market buy Director bought 20,065 shares at $3.96 ($79,457)
  7. 4 Open-market buy Director bought 20,000 shares at $3.90 ($78,000)
  8. 4 Open-market buy Director bought 23,300 shares at $3.72 ($86,676)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Other acquisition COO & CFO acquired 1,634 shares (other)
  15. 4 Open-market buy Director bought 10,000 shares at $4.49 ($44,900)
  16. 4 Open-market buy Director bought 10,000 shares at $3.91 ($39,100)
  17. 4 Open-market buy Director bought 5,000 shares at $3.99 ($19,950)
  18. 4 Open-market buy Director bought 45,000 shares at $4.84 ($217,800)
  19. 4 Open-market buy Director bought 15,600 shares at $4.88 ($76,128)
  20. 4 Open-market buy Director bought 10,000 shares at $4.80 ($48,000)

Page 6 of 24 · 471 filings